Cariprazine
Back to searchMolecule Structure
Scientific Name
Cariprazine
Description of the Drug
Cariprazine is an atypical antipsychotic used to treat schizophrenia and acute manic or mixed episodes due to bipolar I disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06016
http://www.drugbank.ca/drugs/DB06016
Brand Name(s)
Reagila
Company Owner(s)
Allergan Sales Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D3 receptor | SINGLE PROTEIN | MODULATOR | CHEMBL234 |
| Dopamine D2 receptor | SINGLE PROTEIN | MODULATOR | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL184342 | ||
| DrugBank | DB06016 | ||
| PubChem: Thomson Pharma | 24759793 | ||
| LINCS | LSM-45253 | ||
| Nikkaji | J2.875.023D | ||
| PDBe | 7RU | ||
| BindingDB | 50443101 | 50382290 | |
| DrugCentral | 5037 | ||
| ChemicalBook | CB22563442 | ||
| Guide to Pharmacology | 7671 | ||
| rxnorm | VRAYLAR | CARIPRAZINE HYDROCHLORIDE | CARIPRAZINE |
| ChEBI | 90933 | ||
| ZINC | ZINC000100907004 |
